Your hair. Your health. Your identity.Start today
Amma™ (Portable Scalp Cooling System) is indicated for adults and is appropriate for patients with solid tumors.
“Cancer patients undergoing chemotherapy are dealing with the hardest challenge one can face; keeping their hair is critical to their mental health, their sense of self, and their recovery process.”
Kate Dilligan, CEO
Cooler Heads was founded in 2018 by Kate Dilligan, a tech entrepreneur and breast cancer survivor, to protect the dignity, privacy, and identity of cancer patients. After Kate was diagnosed with breast cancer, she spent $8,000 on traditional cold cap therapy.
After talking with countless cancer patients frustrated by the high cost, poor fit, and difficulty of use of existing methods, Kate was determined to engineer a better way.
Easy to use
Amma™ is designed to be portable and wholly self-administered by the patient. Due to the mobility of the unit, the patient can leave the infusion chair to complete their scalp cooling therapy.
Patient receives Amma™
Set up Amma™ components
Watch the self-demo tutorial
Start helping your hair
Cooler Heads transforms life for people diagnosed with cancer by giving them more control over how they experience the side effects of treatment. Cooler Heads' debut product is Amma™, an affordable and transportable scalp-cooling system that democratizes the innovative therapy. Amma™ gives people with cancer a choice in whether they lose their hair during chemotherapy. This impacts more than how they look; it impacts their entire sense of self and can improve their mental health and their recovery.
Patented and cleared by the FDA, Amma™ is the world's first scalp-cooling solution that people administer themselves. It makes scalp-cooling accessible to anyone, anywhere. That means people spend less time in infusion centers, and more time living life on their own terms.
Kate and two of her nieces during Christmas 2016 halfway through 8 cycles of chemo.
December 10, 2021